High-Dose Vitamin D3 and Tonsillectomy as Therapeutic Management in Henoch–Schönlein Purpura Following Hepatitis B Vaccination: A Rare Case Report
Abstract
Henoch–Schönlein purpura (HSP) is an immunoglobulin A (IgA)-mediated systemic vasculitis, which is one of the rare adverse reactions to hepatitis B vaccination. Low vitamin D levels were found to be present in the majority of HSP patients.
A 19-year-old woman was admitted with a purpuric rash on bilateral lower limbs and joint pain on her left index finger in January 2020. A previous history of rash occurred one week after the patient received her first dose of recombinant hepatitis-B vaccination. Routine hematological examination, creatinine, urinalysis, C3, and C4 showed normal results. HBsAg, Anti-HCV, and ANA tests were negative, and anti-HBs were elevated. Vitamin D is very low. The patient was diagnosed with HSP and given mycophenolate mofetil, methylprednisolone, vitamin D3, and folic acid. Within 1 month of therapy, the rash still occurred frequently, so mycophenolate mofetil was changed to mycophenolic acid, the dose of methylprednisolone was increased and fexofenadine was administered. In the next 3 months, the rash has improved. However, patients reported knee joint pain and hair loss. In May 2021, the patient underwent tonsillectomy due to acute exacerbation of chronic tonsillitis. Thereafter, the patient reported that the rash had completely resolved and never worsened, and the vitamin D assay was normal.
Hepatitis B vaccination is one of the etiologies of HSP, although it is rare, so it is important to ask about the vaccination history in patients with suspected HSP. Correction of vitamin D and performing tonsillectomy provide better treatment results in HSP cases in this patient.
Keywords
References
López Meiller MJ, Cavallasca JA, Maliandi MDR, Nasswetter GG. Henoch-SchöNlein purpura in adults. Clinics (Sao Paulo) [Internet]. 2008 [cited 2022 Nov 29];63(2):273. Available from: /pmc/articles/PMC2664214/
Lei W te, Tsai PL, Chu SH, et al. Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database. Pediatr Rheumatol Online J [Internet]. 2018 Apr 16 [cited 2022 Nov 29];16(1). Available from: /PMC/articles/PMC5902957/
Rigante D, Castellazzi L, Bosco A, Esposito S. Is there a crossroad between infections, genetics, and Henoch–Schönlein purpura? Autoimmun Rev. 2013;12(10):1016–21.
Jain SK, Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun. 2013;437(1):7–11.
Beyazit Y, Kocak E, Tanoglu A, Kekilli M. Oxidative stress might play a role in low serum vitamin D associated liver fibrosis among patients with autoimmune Hepatitis. Digestive Diseases and Sciences 2015 60:4 [Internet]. 2015 Jan 14 [cited 2022 Nov 29];60(4):1106–8. Available from: https://link.springer.com/article/10.1007/s10620-015-3526-y
Murdaca G, Tonacci A, Negrini S, et al. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. Autoimmun Rev. 2019;18(9):102350.
Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36.
Fan L, Liu H, Wang YC, Chen L, Zhou JJ, Cui YX. [Association of serum vitamin D level with severity and treatment in children with Henoch-Schönlein purpura]. Zhongguo Dang Dai Er Ke Za Zhi [Internet]. 2017 Jul 1 [cited 2022 Nov 29];19(7):796–9. Available from: https://europepmc.org/articles/PMC7389916
Dong X, Zhong T, Huang Y, Yi L, Zeng H, Zhong X. A case-control study on the relationship between serum 25-hydroxy vitamin D and the risk of Henoch-Schonlein purpura. Chongqing Medicine [Internet]. 2017 [cited 2022 Nov 29];1076-8,81. Available from: http://dx.doi.org/10.3969/j.issn.1671-8348.2017.08.022
Pattyn J, Hendrickx G, Vorsters A, van Damme P. Hepatitis B vaccines. J Infect Dis [Internet]. 2021;224(12 Suppl 2):S343–51. Available from: http://dx.doi.org/10.1093/infdis/jiaa668
Chave TA, Neal C, Camp R. Henoch‐Schönlein purpura following hepatitis B vaccination. http://dx.doi.org/101080/09546630310004199 [Internet]. 2009 Sep [cited 2022 Nov 29];14(3):179–81. Available from: https://www.tandfonline.com/doi/abs/10.1080/09546630310004199
Zaas A, Scheel P, Venbrux A, Hellmann DB. Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. J Rheumatol [Internet]. 2001;28(5):1116–20. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11361200
Allen MB, Cockwell P, Page RL. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax [Internet]. 1993;48(5):580–1. Available from: http://dx.doi.org/10.1136/thx.48.5.580
Bui-Quang D, Thomas E, Riols M, et al. Cutaneous vasculitis after Hepatitis B vaccination with recombinant vaccine in a renal transplant patient. Presse Med [Internet]. 1998;27(26):1321–3. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9779046
Chave T, Neal C, Camp R. Henoch-Schönlein purpura following Hepatitis B vaccination. J Dermatolog Treat [Internet]. 2003;14(3):179-81. Available from: http://dx.doi.org/ 10.1080/09546630310004199
Drucker Y, Prayson RA, Bagg A, Calabrese LH. Lymphocytic vasculitis presenting as diffuse subcutaneous edema after Hepatitis B virus vaccine. J Clin Rheumatol [Internet]. 1997;3(3):158–61. Available from: http://dx.doi.org/10.1097/00124743-199706000-00010
Bourgeais AM, Dore MX, Croue A, Leclech C, Verret JL. Cutaneous polyarteritis nodosa following hepatitis B vaccination. Ann Dermatol Venereol [Internet]. 2003;130(2 Pt 1):205–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12671586
Saadoun D, Cacoub P, Mahoux D, Sbai A, Piette JC. Postvaccine vasculitis: a report of three cases. Rev Med Interne [Internet]. 2001;22(2):172–6. Available from: http://dx.doi.org/10.1016/s0248-8663(00)00307-6
Masse I, Descoffres MC. Hypersensitivity vasculitis after Hepatitis B vaccination. Presse Med [Internet]. 1998;27(20):965–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9767839
Maillefert JF, Sibilia J, Toussirot E, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) [Internet]. 1999;38(10):978–83. Available from: http://dx.doi.org/10.1093/rheumatology/38.10.978
Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schönlein Purpura: A literature review. Acta Derm Venereol [Internet]. 2017;97(10):1160–6. Available from: http://dx.doi.org/10.2340/00015555-2733
le Hello C. Vasculitis associated with antiviral vaccines and antiviral agents. Pathol Biol (Paris) [Internet]. 1999;47(3):252–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10214618
Maritati F, Canzian A, Fenaroli P, Vaglio A. Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy. Presse Med [Internet]. 2020;49(3):104035. Available from: http://dx.doi.org/10.1016/j.lpm.2020.104035
Barbaud A, Deschildre A, Watson J, Raison-Peyron N, Tréchot P. Hypersensitivity and vaccines: an update. Eur J Dermatol [Internet]. 2013;23(2):135–41. Available from: http://dx.doi.org/10.1684/ejd.2012.1842
Kamen B. Folate and antifolate pharmacology. Semin Oncol [Internet]. 1997;24(5 Suppl 18):S18-30-S18-39. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9420019
Mölzer C, Wilson HM, Kuffova L, Forrester JV. A role for folate in microbiome-linked control of autoimmunity. J Immunol Res [Internet]. 2021;2021:9998200. Available from: http://dx.doi.org/10.1155/2021/9998200
Amon U, Yaguboglu R, Ennis M, Holick MF, Amon J. Safety data in patients with autoimmune diseases during treatment with high doses of vitamin D3 according to the “Coimbra protocol”. Nutrients [Internet]. 2022;14(8):1575. Available from: http://dx.doi.org/10.3390/nu14081575
Cadegiani FA. Remission of severe myasthenia gravis after massive-dose vitamin D treatment. Am J Case Rep [Internet]. 2016;17:51–4. Available from: http://dx.doi.org/10.12659/ajcr.894849
Alhuzaim ON, Aljohani N. Effect of vitamin D3 on untreated graves’ disease with vitamin D deficiency. Clin Med Insights Case Rep [Internet]. 2014;7:83–5. Available from: http://dx.doi.org/10.4137/CCRep.S13157
Georgiev T, Angelov AK. Modifiable risk factors in knee osteoarthritis: treatment implications. Rheumatol Int [Internet]. 2019;39(7):1145–57. Available from: http://dx.doi.org/10.1007/s00296-019-04290-z
Dantas LO, Moreira R de FC, Norde FM, Mendes Silva Serrao PR, Alburquerque-Sendín F, Salvini TF. The effects of cryotherapy on pain and function in individuals with knee osteoarthritis: a systematic review of randomized controlled trials. Clin Rehabil [Internet]. 2019;33(8):1310–9. Available from: http://dx.doi.org/10.1177/0269215519840406
Luan L, Bousie J, Pranata A, Adams R, Han J. Stationary cycling exercise for knee osteoarthritis: A systematic review and meta-analysis. Clin Rehabil [Internet]. 2021;35(4):522–33. Available from: http://dx.doi.org/10.1177/0269215520971795
Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: A review of the literature. Cureus [Internet]. 2020;12(5):e8320. Available from: http://dx.doi.org/10.7759/cureus.8320
Gonzalez-Gay MA, Calviño MC, Vazquez-Lopez ME, et al. Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children. Clin Exp Rheumatol [Internet]. 2004;22(6):781–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15638057
Yan M, Wang Z, Niu N, Zhao J, Peng J. Relationship between chronic tonsillitis and Henoch-Schonlein purpura. Int J Clin Exp Med [Internet]. 2015;8(8):14060–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26550368
Iwamoto M, Wakabayashi M, Hanada S, Kobayashi N, Hata T, Ando R. Case of Henoch-Schönlein purpura nephritis successfully treated with tonsillectomy and steroid pulse therapy. Nihon Jinzo Gakkai Shi [Internet]. 2009;51(4):484–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19601558
Iwazu Y, Akimoto T, Muto S, Kusano E. Clinical remission of Henoch–Schönlein purpura nephritis after a monotherapeutic tonsillectomy. Clin Exp Nephrol [Internet]. 2011;15(1):132–5. Available from: http://dx.doi.org/10.1007/s10157-010-0345-5.
Refbacks
- There are currently no refbacks.
This work is licensed under a